Figure 1.
Increasing Tx biosynthesis during atherogenesis in LDLR-KO mice. Excretion of the major urinary metabolite of Tx, 2,3-dinor TxB2, in LDLR-KO mice on a Western-type diet receiving placebo (open bars), indomethacin (hatched bars), or nimesulide (closed bars) at 8 weeks of age and after 18 weeks of treatment (26 weeks of age). (*, P < 0.001.)